CMS and FDA announce RAPID Medicare coverage for breakthrough medical devices

The Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) have announced the RAPID initiative to facilitate Medicare coverage for breakthrough medical devices. This announcement marks a coordinated effort to accelerate the availability of innovative medical technologies to the patient population. For the medical device sector, this program aims to streamline the path from regulatory clearance to reimbursement. The initiative represents a significant policy update for manufacturers seeking to bring high-priority devices to the U.S. market.